Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis
Status:
Not yet recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy of immunoadsorption therapy (IA) on
improving the neurological status of severe pediatric anti-NMDAR encephalitis patients.